Just out: Our multicenter study comparing Uromonitor® DNA assay to #UrineCytology for #BladderCancer
✅ TERT & FGFR-3 mutations strongly predict UCB
❌ 93.3% specificity, but 49.3% sensitivity only
❌ KRAS mutations lacked predictive value.
🤔 The quest for optimal non-invasive #biomarker continues
✅ TERT & FGFR-3 mutations strongly predict UCB
❌ 93.3% specificity, but 49.3% sensitivity only
❌ KRAS mutations lacked predictive value.
🤔 The quest for optimal non-invasive #biomarker continues
Comments